{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:38:14Z","timestamp":1783078694330,"version":"3.54.6"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10067-024-06934-3","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T16:01:46Z","timestamp":1712073706000},"page":"1541-1550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A predictive model for premature atherosclerosis in systemic lupus erythematosus based on clinical characteristics"],"prefix":"10.1007","volume":"43","author":[{"given":"Ruyu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renge","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5444-3435","authenticated-orcid":false,"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"issue":"6","key":"6934_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos GC (2020) Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol 21(6):605\u2013614","journal-title":"Nat Immunol"},{"key":"6934_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/joim.13557","volume":"293","author":"J Frosteg\u00e5rd","year":"2023","unstructured":"Frosteg\u00e5rd J (2023) Systemic lupus erythematosus and cardiovascular disease. J Intern Med 293:48\u201362","journal-title":"J Intern Med"},{"issue":"3","key":"6934_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/09612033221147471","volume":"32","author":"N Bello","year":"2023","unstructured":"Bello N, Meyers KJ, Workman J, Hartley L, McMahon M (2023) Cardiovascular events and risk in patients with systemic lupus erythematosus: systematic literature review and meta-analysis. Lupus 32(3):325\u2013341","journal-title":"Lupus"},{"issue":"1","key":"6934_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/acr.24988","volume":"75","author":"T Taylor","year":"2023","unstructured":"Taylor T, Anastasiou C, Ja C, Rush S, Trupin L, Dall'Era M et al (2023) Causes of death among individuals with systemic lupus erythematosus by race and ethnicity: a population-based study. Arthritis Care Res 75(1):61\u201368","journal-title":"Arthritis Care Res"},{"issue":"10","key":"6934_CR5","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ (2022) Atherosclerosis: recent developments. Cell 185(10):1630\u20131645","journal-title":"Cell"},{"key":"6934_CR6","doi-asserted-by":"publisher","first-page":"117267","DOI":"10.1016\/j.atherosclerosis.2023.117267","volume":"384","author":"J Crooijmans","year":"2023","unstructured":"Crooijmans J, Singh S, Naqshband M, Bruikman CS, Pinto-Sietsma S-J (2023) Premature atherosclerosis: an analysis over 39 years in the Netherlands. Implications for young individuals in high-risk families. Atherosclerosis 384:117267","journal-title":"Atherosclerosis"},{"issue":"7","key":"6934_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jamacardio.2021.0683","volume":"6","author":"MT Lee","year":"2021","unstructured":"Lee MT, Mahtta D, Ramsey DJ, Liu J, Misra A, Nasir K et al (2021) Sex-related disparities in cardiovascular health care among patients with premature atherosclerotic cardiovascular disease. JAMA Cardiol 6(7):782\u2013790","journal-title":"JAMA Cardiol"},{"issue":"2","key":"6934_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/BOR.0000000000000773","volume":"33","author":"BD Appleton","year":"2021","unstructured":"Appleton BD, Major AS (2021) The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy. Curr Opin Rheumatol 33(2):211\u2013218","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"6934_CR9","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1093\/rheumatology\/key233","volume":"57","author":"E Kravvariti","year":"2018","unstructured":"Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG (2018) Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity. Rheumatology (Oxford) 57(12):2158\u20132166","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6934_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/kead184","volume":"63","author":"N Papazoglou","year":"2024","unstructured":"Papazoglou N, Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG (2024) The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus. Rheumatology (Oxford) 63(1):50\u201357","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"6934_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/annrheumdis-2018-214802","volume":"78","author":"K Tselios","year":"2019","unstructured":"Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M (2019) All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Ann Rheum Dis 78(6):802\u2013806","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"6934_CR12","first-page":"e596","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ et al (2019) 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 140(11):e596\u2013e646","journal-title":"Circulation"},{"issue":"29","key":"6934_CR13","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315\u20132381","journal-title":"Eur Heart J"},{"issue":"10","key":"6934_CR14","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","volume":"44","author":"JM Esdaile","year":"2001","unstructured":"Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R et al (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331\u20132337","journal-title":"Arthritis Rheum"},{"issue":"3","key":"6934_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/eurjpc\/zwaa256","volume":"28","author":"GC Drosos","year":"2021","unstructured":"Drosos GC, Konstantonis G, Sfikakis PP, Tektonidou MG (2021) Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus. Eur J Prev Cardiol 28(3):346\u2013352","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"6934_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/art.38204","volume":"66","author":"M McMahon","year":"2014","unstructured":"McMahon M, Skaggs BJ, Grossman JM, Sahakian L, Fitzgerald J, Wong WK et al (2014) A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol 66(1):130\u2013139","journal-title":"Arthritis Rheumatol"},{"key":"6934_CR17","doi-asserted-by":"publisher","first-page":"622216","DOI":"10.3389\/fimmu.2021.622216","volume":"12","author":"H Xing","year":"2021","unstructured":"Xing H, Pang H, Du T, Yang X, Zhang J, Li M, Zhang S (2021) Establishing a risk prediction model for atherosclerosis in systemic lupus erythematosus. Front Immunol 12:622216","journal-title":"Front Immunol"},{"key":"6934_CR18","doi-asserted-by":"publisher","first-page":"106388","DOI":"10.1016\/j.compbiomed.2022.106388","volume":"152","author":"C Liu","year":"2023","unstructured":"Liu C, Zhou Y, Zhou Y, Tang X, Tang L, Wang J (2023) Identification of crucial genes for predicting the risk of atherosclerosis with system lupus erythematosus based on comprehensive bioinformatics analysis and machine learning. Comput Biol Med 152:106388","journal-title":"Comput Biol Med"},{"issue":"9","key":"6934_CR19","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71(9):1400\u20131412","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"6934_CR20","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686","journal-title":"Arthritis Rheum"},{"issue":"7","key":"6934_CR21","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/1529-0131(199807)41:7<1326::AID-ART29>3.0.CO;2-4","volume":"41","author":"A Tsutsumi","year":"1998","unstructured":"Tsutsumi A, Ichikawa K, Atsumi T, Matsuura E, Koike T, Krilis SA (1998) Use of various methods for anticardiolipin detection in the updated American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: comment on the letter by Hochberg. Arthritis Rheum 41(7):1326\u20131327","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6934_CR22","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"issue":"1","key":"6934_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS et al (2019) Atherosclerosis. Nat Rev Dis Primers 5(1):56","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"6934_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/annrheumdis-2012-203101","volume":"73","author":"A Corrales","year":"2014","unstructured":"Corrales A, Gonz\u00e1lez-Juanatey C, Peir\u00f3 ME, Blanco R, Llorca J, Gonz\u00e1lez-Gay MA (2014) Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 73(4):722\u2013727","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6934_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000097034","volume":"23","author":"PJ Touboul","year":"2007","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al (2007) Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23(1):75\u201380","journal-title":"Cerebrovasc Dis"},{"issue":"30","key":"6934_CR26","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/sim.3148","volume":"26","author":"W Sauerbrei","year":"2007","unstructured":"Sauerbrei W, Royston P, Binder H (2007) Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 26(30):5512\u20135528","journal-title":"Stat Med"},{"issue":"4","key":"6934_CR27","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173\u2013ee80","journal-title":"Lancet Oncol"},{"issue":"10","key":"6934_CR28","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.24328","volume":"72","author":"M Barbhaiya","year":"2020","unstructured":"Barbhaiya M, Feldman CH, Chen SK, Guan H, Fischer MA, Everett BM, Costenbader KH (2020) Comparative risks of cardiovascular disease in patients with systemic lupus erythematosus, diabetes mellitus, and in general medicaid recipients. Arthritis Care Res 72(10):1431\u20131439","journal-title":"Arthritis Care Res"},{"issue":"5","key":"6934_CR29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s10753-021-01455-6","volume":"44","author":"AB Reiss","year":"2021","unstructured":"Reiss AB, Jacob B, Ahmed S, Carsons SE, DeLeon J (2021) Understanding accelerated atherosclerosis in systemic lupus erythematosus: toward better treatment and prevention. Inflammation 44(5):1663\u20131682","journal-title":"Inflammation"},{"issue":"25","key":"6934_CR30","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa035471","volume":"349","author":"MJ Roman","year":"2003","unstructured":"Roman MJ, Shanker B-A, Davis A, Lockshin MD, Sammaritano L, Simantov R et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2399\u20132406","journal-title":"N Engl J Med"},{"issue":"2","key":"6934_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3899\/jrheum.150488","volume":"43","author":"SD Kay","year":"2016","unstructured":"Kay SD, Poulsen MK, Diederichsen ACP, Voss A (2016) Coronary, carotid, and lower-extremity atherosclerosis and their interrelationship in Danish patients with systemic lupus erythematosus. J Rheumatol 43(2):315\u2013322","journal-title":"J Rheumatol"},{"issue":"1","key":"6934_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/joim.13557","volume":"293","author":"J Frosteg\u00e5rd","year":"2023","unstructured":"Frosteg\u00e5rd J (2023) Systemic lupus erythematosus and cardiovascular disease. J Intern Med 293(1):48\u201362","journal-title":"J Intern Med"},{"issue":"1","key":"6934_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","volume":"15","author":"G-C Wu","year":"2016","unstructured":"Wu G-C, Liu H-R, Leng R-X, Li X-P, Li X-M, Pan H-F, Ye D-Q (2016) Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis. Autoimmun Rev 15(1):22\u201337","journal-title":"Autoimmun Rev"},{"issue":"11","key":"6934_CR34","first-page":"e563","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ et al (2019) 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation 140(11):e563\u2013ee95","journal-title":"Circulation"},{"issue":"10","key":"6934_CR35","doi-asserted-by":"publisher","first-page":"102371","DOI":"10.1016\/j.autrev.2019.102371","volume":"18","author":"P Munguia-Realpozo","year":"2019","unstructured":"Munguia-Realpozo P, Mendoza-Pinto C, Sierra Benito C, Escarcega RO, Garcia-Carrasco M, Mendez Martinez S et al (2019) Systemic lupus erythematosus and hypertension. Autoimmun Rev 18(10):102371","journal-title":"Autoimmun Rev"},{"issue":"9","key":"6934_CR36","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1136\/ard.2010.142737","volume":"70","author":"M McMahon","year":"2011","unstructured":"McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, Ragavendra N et al (2011) High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 70(9):1619\u20131624","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6934_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/acr.22751","volume":"68","author":"F Rees","year":"2016","unstructured":"Rees F, Doherty M, Grainge M, Lanyon P, Davenport G, Zhang W (2016) Burden of comorbidity in systemic lupus erythematosus in the UK, 1999-2012. Arthritis Care Res 68(6):819\u2013827","journal-title":"Arthritis Care Res"},{"issue":"8","key":"6934_CR38","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/rheumatology\/keab882","volume":"61","author":"G Evangelatos","year":"2022","unstructured":"Evangelatos G, Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG (2022) Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3\u2009year prospective study. Rheumatology (Oxford) 61(8):3408\u20133413","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"6934_CR39","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ram\u00f3n E et al (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74(6):1011\u20131018","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"6934_CR40","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1093\/rheumatology\/keaa116","volume":"59","author":"A Bettiol","year":"2020","unstructured":"Bettiol A, Emmi G, Finocchi M, Silvestri E, Urban ML, Mattioli I et al (2020) Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. Rheumatology (Oxford) 59(12):3709\u20133716","journal-title":"Rheumatology (Oxford)"},{"key":"6934_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijcard.2019.10.042","volume":"300","author":"C Selmi","year":"2020","unstructured":"Selmi C, De Santis M, Battezzati PM, Generali E, Lari SA, Ceribelli A et al (2020) Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population. Int J Cardiol 300:209\u2013213","journal-title":"Int J Cardiol"},{"key":"6934_CR42","doi-asserted-by":"publisher","first-page":"102813","DOI":"10.1016\/j.jaut.2022.102813","volume":"128","author":"MG Tektonidou","year":"2022","unstructured":"Tektonidou MG (2022) Cardiovascular disease risk in antiphospholipid syndrome: thrombo-inflammation and atherothrombosis. J Autoimmun 128:102813","journal-title":"J Autoimmun"},{"issue":"Suppl5","key":"6934_CR43","doi-asserted-by":"publisher","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","volume":"59","author":"G Ruiz-Irastorza","year":"2020","unstructured":"Ruiz-Irastorza G, Bertsias G (2020) Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs. Rheumatology (Oxford) 59(Suppl5):v69\u2013v81","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6934_CR44","doi-asserted-by":"publisher","first-page":"e000157","DOI":"10.1136\/lupus-2016-000157","volume":"3","author":"D Apostolopoulos","year":"2016","unstructured":"Apostolopoulos D, Kandane-Rathnayake R, Raghunath S, Hoi A, Nikpour M, Morand EF (2016) Independent association of glucocorticoids with damage accrual in SLE. Lupus Sci Med 3(1):e000157","journal-title":"Lupus Sci Med"},{"issue":"7","key":"6934_CR45","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s10238-023-01084-3","volume":"23","author":"M Merashli","year":"2023","unstructured":"Merashli M, Bucci T, Arcaro A, Gentile F, Ames PRJ (2023) Subclinical atherosclerosis in Behcet\u2019s disease and its inverse relation to azathioprine use: an updated meta-analysis. Clin Exp Med 23(7):3431\u20133442","journal-title":"Clin Exp Med"},{"key":"6934_CR46","doi-asserted-by":"publisher","first-page":"104234","DOI":"10.1016\/j.mvr.2021.104234","volume":"138","author":"AV de Melo Bisneto","year":"2021","unstructured":"de Melo Bisneto AV, Fernandes AS, VdS VS, V\u00e9ras JH, ETS S, da Silva Santos AF et al (2021) Anti-angiogenic activity of azathioprine. Microvasc Res 138:104234","journal-title":"Microvasc Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-06934-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T06:03:40Z","timestamp":1713161020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-06934-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6934"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-06934-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"During the preparation of this work, the authors used ChatGPT 4.0 in order to polish the language of this article. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}]}}